Related Experiment Videos
Animal model of para-aortic lymph node metastasis
S Tsutsumi1, H Kuwano, N Morinaga
1First Department of Surgery, Gunma University School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan. chuchumi@showa.gunma-u.ac.jp
Cancer Letters
|June 19, 2001
Summary
Researchers developed a novel rectal cancer metastasis model in nude mice. This model effectively demonstrated lymph node metastasis and the efficacy of uracil/tegafur (UFT) in inhibiting tumor growth and spread.
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Lymph node metastasis is a critical factor in cancer progression and patient prognosis.
- Developing reliable experimental models is essential for studying metastasis and evaluating anti-cancer therapies.
Purpose of the Study:
- To establish a reproducible experimental model of lymph node metastasis using intra-rectal implantation of human cancer cells in nude mice.
- To investigate the efficacy of uracil/tegafur (UFT) in suppressing rectal tumor growth and lymph node metastasis within this model.
Main Methods:
- Intra-rectal injection of four human cancer cell lines (TE-1, MKN-45, HT-29, MIAPaca-2) suspended in Matrigel into the submucosal layer of nude mouse rectums.
- Monitoring tumor development, para-aortic lymph node metastasis, and other distant metastatic sites.
- Administering uracil/tegafur (UFT) orally to evaluate its impact on primary tumor volume and lymph node metastasis.
Main Results:
- All tested human cancer cell lines successfully formed locally aggressive rectal tumors and led to para-aortic lymph node metastasis.
- The model did not produce distant metastases in organs such as the liver, spleen, lungs, or peritoneum.
- Oral administration of UFT significantly reduced primary tumor volume and inhibited lymph node metastasis.
Conclusions:
- The established intra-rectal implantation model in nude mice is effective for studying human rectal cancer lymph node metastasis.
- This model provides a valuable platform for evaluating the therapeutic potential of anti-cancer agents like UFT against rectal cancer metastasis.